A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors

Overview of attention for article published in Frontiers in Pharmacology, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 14 X posts from 11 X users, with an upper bound of 20,681 followers.

RT @iuboag: Ya está disponible la versión final del trabajo colaborativo de @BioLabULL en el seno de la acción COST @stratagem_cost @Cien…

08 Mar 2022

Reply Repost Favourite

RT @BioLabULL: Available online the final version of our multicenter study under @COSTprogramme @stratagem_cost A Comprehensive Evaluation…

08 Mar 2022

Reply Repost Favourite

RT @BioLabULL: Available online the final version of our multicenter study under @COSTprogramme @stratagem_cost A Comprehensive Evaluation…

08 Mar 2022

Reply Repost Favourite

New Research: A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors https://t.co/q4Xs0f883Q #pharmacology

07 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.